Haymaker Acquisition Corp V flags going-concern doubt
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Haymaker Acquisition Corp V (HYAC), a blank-check company, reported $139,689 net income for the three months ended September 30, 2026, as $299,871 of trust-account interest exceeded $160,182 of operating and formation costs. It has not begun operations or generated operating revenue, selected a business-combination target, or held substantive discussions with one.
At September 30, 2026, cash outside the trust was $1,796,509 and trust investments were $287,799,871. The company completed its IPO of 28,750,000 units at $10.00 per unit, generating $287,500,000 in gross proceeds, and sold 5,333,333 private placement warrants for $8,000,000. A $12,250,000 deferred underwriting fee is payable upon a business combination, subject to the underwriting agreement.
Management says it lacks liquidity to sustain operations for a reasonable period, considered to be at least one year from issuance, raising substantial doubt about the company’s ability to continue as a going concern. Management plans to complete an initial business combination before the end of the 24-month Completion Window following the September 18, 2026 IPO closing; if unable, the company will cease operations except to liquidate.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- None.
Negative
- Major pointManagement’s liquidity assessment raises substantial doubt about the company’s ability to continue as a going concern.
Filing Explained
Public holders can elect cash redemption when a business combination is completed, rather than carry their shares into the combined company.
As of
Each IPO unit includes one-third of a warrant, and the 5,333,333 private-placement warrants each allow purchase of one Class A share for
Public shareholders may redeem all or part of their shares for a pro-rata cash amount from the trust in connection with a business combination, either through a shareholder vote or a tender offer.
Key Figures
Key Terms
Business Combination technical
Trust Account financial
Permitted Withdrawals financial
deferred underwriting discount financial
going concern financial
temporary equity financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What happens to HYAC shareholders if it does not complete a business combination?
When can HYAC private placement warrants be transferred?
AI-generated analysis. How Rhea-AI works. Not financial advice.
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
| Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
| ☒ | Smaller reporting company | |||||
| Emerging growth company |
HAYMAKER ACQUISITION CORP V
FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2026
TABLE OF CONTENTS
| Page | ||||
| Part I. Interim Financial Information |
||||
| Item 1. Interim Financial Statements |
||||
| Condensed Balance Sheets as of September 30, 2026 and December 31, 2025 (Unaudited) |
1 | |||
| Condensed Statements of Operations for the Three and Nine Months Ended September 30, 2026 (Unaudited) |
2 | |||
| Condensed Statements of Changes in Shareholders’ Deficit for the Three and Nine Months Ended September 30, 2026 (Unaudited) |
3 | |||
| Condensed Statement of Cash Flows for the Nine Months Ended September 30, 2026 (Unaudited) |
4 | |||
| Notes to Condensed Financial Statements (Unaudited) |
5 | |||
| Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations |
16 | |||
| Item 3. Quantitative and Qualitative Disclosures About Market Risk |
18 | |||
| Item 4. Controls and Procedures |
18 | |||
| Part II. Other Information |
||||
| Item 1. Legal Proceedings |
18 | |||
| Item 1A. Risk Factors |
18 | |||
| Item 2. Unregistered Sales of Equity Securities and Use of Proceeds |
18 | |||
| Item 3. Defaults Upon Senior Securities |
19 | |||
| Item 4. Mine Safety Disclosures |
19 | |||
| Item 5. Other Information |
19 | |||
| Item 6. Exhibits |
20 | |||
| Signatures |
21 | |||
September 30, 2026 |
December 31, 2025 |
|||||||
ASSETS |
||||||||
Current assets |
||||||||
Cash |
$ | $ | ||||||
Prepaid expenses |
||||||||
Prepaid insurance |
||||||||
Total Current Assets |
||||||||
Prepaid insurance – long-term |
||||||||
Investments held in Trust Account |
||||||||
Deferred offering costs |
||||||||
Total Assets |
$ |
$ |
||||||
LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT |
||||||||
Current liabilities |
||||||||
Accrued expenses |
$ | $ | ||||||
Accrued offering costs |
||||||||
Promissory note – related party |
||||||||
Total Current Liabilities |
||||||||
Deferred underwriting fee |
||||||||
Total Liabilities |
||||||||
Commitments and Contingencies |
||||||||
Class A ordinary shares subject to possible redemption, |
||||||||
Shareholders’ (Deficit) Equity |
||||||||
Preference shares, $ |
||||||||
Class A ordinary shares, $ |
||||||||
Class B ordinary shares, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
Total Shareholders’ (Deficit) Equity |
( |
) |
||||||
TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ (DEFICIT) EQUITY |
$ |
$ |
||||||
| (1) | Included up to |
| (2) | In August 2 |
For the Three Months Ended September 30, |
For the Nine Months Ended September 30, |
|||||||
2026 |
2026 |
|||||||
Operating and formation costs |
$ | $ | ||||||
Loss from operations |
( |
( ) |
||||||
Other income: |
||||||||
Interest earned on investments held in Trust Account |
||||||||
Total other income |
||||||||
Net income |
$ |
$ |
||||||
Weighted average shares outstanding, Class A ordinary shares, basic and diluted |
||||||||
Basic and diluted net income per share, Class A ordinary shares |
$ |
$ |
||||||
Weighted average shares outstanding, Class B ordinary shares, basic |
||||||||
Basic net income per share, Class B ordinary shares |
$ |
$ |
||||||
Weighted average shares outstanding, Class B ordinary shares, diluted(1)(2) |
||||||||
Diluted net income per share, Class B ordinary shares |
$ |
$ |
||||||
| (1) | Included up to |
| (2) | In August 2026, the Company issued |
Class A Ordinary Shares |
Class B Ordinary Shares |
Additional Paid-in |
Accumulated |
Total Shareholders’ |
||||||||||||||||||||||||
Shares |
Amount |
Shares(1)(2) |
Amount |
Capital |
Deficit |
Deficit |
||||||||||||||||||||||
Balance – December 31, 2025 |
$ |
$ |
$ |
$ |
( |
) |
$ |
|||||||||||||||||||||
Net loss |
— | — | — | — | ( |
) | ( |
) | ||||||||||||||||||||
Balance – March 31, 2026 (unaudited) |
( |
) |
( |
) | ||||||||||||||||||||||||
Net loss |
— | — | — | — | ( |
) | ( |
) | ||||||||||||||||||||
Balance – June 30, 2026 (unaudited) |
( |
) |
( |
) | ||||||||||||||||||||||||
Accretion for Class A ordinary shares to redemption amount |
— | — | — | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||
Sale of |
— | — | — | — | ||||||||||||||||||||||||
Fair Value of Public Warrants at issuance |
— | — | — | — | ||||||||||||||||||||||||
Allocation of transaction costs to Public Warrants and Private Placement Warrants |
— | — | — | — | ( |
) | ( |
) | ||||||||||||||||||||
Net income |
— | — | — | — | ||||||||||||||||||||||||
Balance – September 30, 2026 (unaudited) |
$ |
$ |
$ | $ |
( |
) |
$ |
( |
) | |||||||||||||||||||
| (1) | Included up to |
| (2) | In August 2 |
Cash Flows from Operating Activities: |
||||
Net income |
$ | |||
Adjustments to reconcile net income to net cash used in operating activities: |
||||
Payment of operating and formation costs through promissory note – related party |
||||
Interest earned on investments held in Trust Account |
( |
) | ||
Changes in operating assets and liabilities: |
||||
Prepaid expenses |
( |
) | ||
Prepaid insurance |
( |
) | ||
Prepaid insurance – long-term |
( |
) | ||
Accrued expenses |
||||
Net cash used in operating activities |
( |
) | ||
Cash Flows from Investing Activities: |
||||
Investment of cash in Trust Account |
( |
) | ||
Net cash used in investing activities |
( |
) | ||
Cash Flows from Financing Activities: |
||||
Proceeds from sale of Units, net of underwriting discounts paid |
||||
Proceeds from sale of Private Placement Warrants |
||||
Proceeds from promissory note - related party |
||||
Repayment of promissory note - related party |
( |
) | ||
Payment of offering costs |
( |
) | ||
Net cash provided by financing activities |
||||
Net Change in Cash |
||||
Cash – Beginning of period |
||||
Cash – End of period |
$ |
|||
Noncash investing and financing activities: |
||||
Offering costs included in accrued offering costs |
$ | |||
Offering costs paid through promissory note - related party |
$ | |||
Prepaid expenses applied to deferred offering costs |
$ | |||
Accretion of Class A ordinary shares to redemption value |
$ | |||
Deferred underwriting fee payable |
$ | |||
Gross proceeds |
$ | |||
Less: |
||||
Proceeds allocated to Public Warrants |
( |
) | ||
Allocated issuance costs |
( |
) | ||
Plus: |
||||
Accretion of carrying value to redemption value |
||||
Class A ordinary shares subject to possible redemption, September 30, 2026 |
$ | |||
| For the Three Months Ended September 30, 2026 |
For the Nine Months Ended September 30, 2026 |
|||||||||||||||
| Class A | Class B | Class A | Class B | |||||||||||||
Basic net income per ordinary share |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net income, as adjusted |
$ | $ | $ | $ | ||||||||||||
Denominator: |
||||||||||||||||
Basic weighted average ordinary shares outstanding |
||||||||||||||||
Basic net income per ordinary share |
$ | $ | $ | $ | ||||||||||||
| For the Three Months Ended September 30, 2026 |
For the Nine Months Ended September 30, 2026 |
|||||||||||||||
| Class A | Class B | Class A | Class B | |||||||||||||
Diluted net income per ordinary share |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net income, as adjusted |
$ | $ | $ | $ | ||||||||||||
Denominator: |
||||||||||||||||
Diluted weighted average ordinary shares outstanding |
||||||||||||||||
Diluted net income per ordinary share |
$ | $ | $ | $ | ||||||||||||
| • | in whole and not in part; |
| • | at a price of $ |
| • | upon a minimum of |
| • | if, and only if, the closing price of the Class A ordinary shares equals or exceeds $ |
| • | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
| • | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
| • | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
Description |
Level | September 30, 2026 |
December 31, 2025 |
|||||||||
Assets: |
||||||||||||
Investments held in Trust Account |
1 | $ | $ | |||||||||
September 18, 2026 |
||||
Underlying stock price |
$ | |||
Exercise price |
$ | |||
Volatility |
% | |||
Implied market adjustment |
% | |||
Risk-free rate |
% | |||
Warrant term (years) |
||||
| September 30, 2026 |
December 31, 2025 |
|||||||
Cash |
$ | $ | ||||||
Investments held in Trust Account |
$ | $ | ||||||
| For the Three Months Ended September 30, 2026 |
For the Nine Months Ended September 30, 2026 |
|||||||
Operating and formation costs |
$ | $ | ||||||
Interest earned on investments held in Trust Account |
$ | $ | ||||||
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Haymaker Acquisition Corp V. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to Haymaker Sponsor V LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the completion of the initial Business Combination (as defined below), the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, including that the conditions of the initial Business Combination are not satisfied. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s final prospectus for its Initial Public Offering filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Overview
We are a blank check company incorporated in the Cayman Islands on November 25, 2025 for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar Business Combination with one or more businesses (the “Business Combination”). We intend to effectuate our Business Combination using cash derived from the proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, our shares, debt or a combination of cash, shares and debt.
We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.
Results of Operations
We have neither engaged in any operations nor generated any revenues to date. Our only activities from November 25, 2025 (inception) through September 30, 2026 were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and identifying a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination. We generate non-operating income in the form of interest income on marketable securities held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the three months ended September 30, 2026, we had net income of $139,689, which consisted of interest earned on investments held in the Trust Account of $299,871, offset by operating and formation costs of $160,182.
For the nine months ended September 30, 2026, we had a net income of $100,658, which consisted of interest earned on investments held in the Trust Account of $299,871, offset by operating and formation costs of $199,213.
Liquidity, Capital Resources and Going Concern
On September 18, 2026, the Company consummated the Initial Public Offering of 28,750,000 Units at $10.00 per Unit, which includes the full exercise of the underwriters’ over-allotment option of 3,750,000 Units, generating gross proceeds of $287,500,000. Simultaneously with the closing of the Initial Public Offering, we completed the sale of 5,333,333 Private Placement Warrants at a price of $1.50 per Private Placement Warrant (each exercisable for one Class A ordinary share at $11.50 per share) in a private placement to the Sponsor and Cantor Fitzgerald & Co., William Blair & Company, L.L.C. and Roth Capital Partners, LLC, generating gross proceeds of $8,000,000.
Following the Initial Public Offering, the full exercise of the over-allotment option, and the sale of the Private Placement Warrants, a total of $287,500,000 was placed in the Trust Account. We incurred $17,948,453, consisting of $5,000,000 of cash underwriting fees, $12,250,000 of deferred underwriting fees, and $698,453 of other offering costs.
For the nine months ended September 30, 2026, net cash used in operating activities was $652,504. Net income of $100,658 was adjusted by non-cash items consisting of $5,000 of operating and formation costs paid by Sponsor through the promissory note – related party and $299,871 of interest earned on investments held in the trust account. Changes in operating assets and liabilities used $458,291 of cash from operating activities.
16
As of September 30, 2026, we had marketable securities held in the Trust Account of $287,799,871 (including $299,871 of interest income) consisting of money market funds, which are invested primarily in U.S. treasury securities. We may withdraw interest for Permitted Withdrawals (up to $250,000 annually for working capital, plus rollover) and to pay our taxes, if any (other than excise or similar taxes). We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete our Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
As of September 30, 2026, we had cash of $1,796,509. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.
In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their affiliates may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into private placement warrants at a price of $1.50 per warrant, at the option of the lender. The warrants would be identical to the Private Placement Warrants.
In connection with our assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements—Going Concern”, management has determined that we currently lack the liquidity we need to sustain operations for a reasonable period of time, which is considered to be at least one year from the date that the unaudited condensed financial statements and the notes thereto included in this report under Item 1. “Financial Statements” are issued as we expect to continue to incur significant costs in pursuit of our acquisition plans. In addition, management has determined that if we are unable to complete an initial business combination by the Completion Window, then we will cease all operations except for the purpose of liquidating. These conditions raise substantial doubt about our ability to continue as a going concern. Our management plans to consummate an initial business combination prior to the end of the Completion Window. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after September 18, 2028. We cannot assure our shareholders that our plans to raise capital or to consummate an initial business combination will be successful.
Off-Balance Sheet Arrangements
We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2026. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.
Contractual Obligations
We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than (i) the deferred underwriting discount, (ii) an agreement to pay Mistral Capital Management LLC, an affiliate of the Company’s Chief Executive Officer and Chief Financial Officer, a monthly fee of $67,500 per month for office space, secretarial and administrative services provided to members of the Company’s management team, and (iii) an agreement with a separate affiliate of the Company’s Chief Executive Officer and Chief Financial Officer to pay $40,000 per month for services rendered prior to the consummation of the Business Combination, which amounts will be accrued from the closing of the Initial Public Offering and will only be payable upon the successful completion of the Business Combination.
The underwriters are entitled to a deferred underwriting discount of $12,250,000, which is presented as a long-term liability in the accompanying balance sheets and will become payable upon the completion of the Company’s initial Business Combination, subject to the terms of the underwriting agreement.
We began incurring fees to Mistral Capital Management LLC on September 16, 2026 and will continue to incur these fees monthly until the earlier of the completion of the Business Combination and our liquidation. For the three and nine months ended September 30, 2026, the Company incurred $33,750 in fees for these services, of which such amount is included in accrued expenses in the accompanying balance sheets.
In addition, commencing on the closing date of the Initial Public Offering, September 18, 2026, the Company entered into an agreement with an affiliate of the Company’s Chief Executive Officer and Chief Financial Officer to pay $40,000 per month for services rendered prior to the consummation of the Business Combination, which amounts will be accrued from the closing of the Initial Public Offering and will only be payable upon the successful completion of the Business Combination. For the three and nine months ended September 30, 2026, the Company incurred $20,000 in fees for these services, of which such amount is included in accrued expenses in the accompanying balance sheets.
The Company granted the underwriters a 45-day option from the date of the Initial Public Offering to purchase up to an additional 3,750,000 units to cover over-allotments, if any. On September 18, 2026, simultaneously with the closing of the Initial Public Offering, the underwriters elected to fully exercise their over-allotment option to purchase an additional 3,750,000 Units at a price of $10.00 per Unit.
Critical Accounting Estimates
The preparation of the unaudited condensed financial statements and notes thereto included in this Report under Item 1. “Financial Statements” in conformity with GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities, income and expenses, and the disclosure of contingent assets and liabilities, in our unaudited condensed financial statements. These accounting estimates require the use of assumptions about matters, some of which are highly uncertain at the time of estimation. Management bases its estimates on historical experience and on various other assumptions it believes to be reasonable under the circumstances, the results of which form the basis for making judgments, and we evaluate these estimates on an ongoing basis. To the extent actual experience differs from the assumptions used, our unaudited condensed financial statements and notes thereto included in this Report under Item 1. “Financial Statements” could be materially affected. As of September 30, 2026, we did not have any critical accounting estimates to be disclosed.
17
Item 6. Exhibits
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
| No. | Description of Exhibit | |
| 1.1 | Underwriting Agreement, dated September 16, 2026, by and between the Company and Cantor Fitzgerald & Co. and William Blair & Company, L.L.C., as representatives of the several underwriters (incorporated herein by reference to Exhibit 1.1 to the Current Report on Form 8-K, filed by the Company on September 22, 2026). | |
| 4.1 | Warrant Agreement, dated September 16, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent (incorporated herein by reference to Exhibit 4.1 to the Current Report on Form 8-K, filed by the Company on September 22, 2026). | |
| 10.1 | Investment Management Trust Agreement, September 16, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as trustee (incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K, filed by the Company on September 22, 2026). | |
| 10.2 | Registration Rights Agreement, dated September 16, 2026, by and among the Company and certain security holders (incorporated herein by reference to Exhibit 10.2 to the Current Report on Form 8-K, filed by the Company on September 22, 2026). | |
| 10.3 | Sponsor Private Placement Warrants Purchase Agreement, dated September 16, 2026, by and between the Company and the Sponsor (incorporated herein by reference to Exhibit 10.3 to the Current Report on Form 8-K, filed by the Company on September 22, 2026). | |
| 10.4 | Underwriters Private Placement Warrants Purchase Agreement, dated September 16, 2026, by and between the Company and the Underwriters (incorporated herein by reference to Exhibit 10.4 to the Current Report on Form 8-K, filed by the Company on September 22, 2026). | |
| 10.5 | Letter Agreement, dated September 16, 2026, by and among the Company, its officers, directors, and the Sponsor (incorporated herein by reference to Exhibit 10.5 to the Current Report on Form 8-K, filed by the Company on September 22, 2026). | |
| 10.6 | Form of Indemnity Agreement (incorporated herein by reference to Exhibit 10.6 to the Registration Statement on Form S-1 (File No. 333- 298544), filed by the Company on August 25, 2026). | |
| 10.7 | Administrative Services Agreement, dated September 16, 2026, by and between the Company and Mistral Capital Management LLC (incorporated herein by reference to Exhibit 10.7 to the Current Report on Form 8-K, filed by the Company on September 22, 2026). | |
| 10.8 | Advisory Services Agreement, dated September 16, 2026, by and between the Company and Forest Crest Holdings LLC (incorporated herein by reference to Exhibit 10.8 to the Current Report on Form 8-K, filed by the Company on September 22, 2026). | |
| 31.1* | Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
| 32.1** | Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
| 101.INS* | XBRL Instance Document | |
| 101.SCH* | XBRL Taxonomy Extension Schema Document | |
| 101.CAL* | XBRL Taxonomy Extension Calculation Linkbase Document | |
| 101.DEF* | XBRL Taxonomy Extension Definition Linkbase Document | |
| 101.LAB* | XBRL Taxonomy Extension Labels Linkbase Document | |
| 101.PRE* | XBRL Taxonomy Extension Presentation Linkbase Document | |
| 104* | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | |
| * | Filed herewith. |
| ** | Furnished herewith |
20
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| HAYMAKER ACQUISITION CORP V | ||||||
| Date: November 13, 2026 |
By: | /s/ Christopher Bradley | ||||
| Name: | Christopher Bradley | |||||
| Title: | Chief Executive Officer, Chief Financial Officer, and Chairman (Principal Executive Officer, Principal Financial and Accounting Officer) | |||||
21